Company Search:
Advanced Search
Sponsored Links
Lonza Group AG Company Snapshot
Lonza Group AG operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Lonza Group AG with three other pharmaceutical manufacturers in Europe: UCB Sa of Belgium (2015 sales of 3.88 billion Euro [US$4.25 billion] of which 100% was Biopharmacy), Shire PLC of the United Kingdom (£4.21 billion [US$5.18 billion] of which 100% was Pharmaceuticals & Genetic Therapies), and Protek OAO (P) which is based in Russia (195.31 billion Russian Rubles [US$3.12 billion] of which 81% was Distribution).

Sales Analysis. During the year ended December of 2015, sales at Lonza Group AG were 3.80 billion Swiss Francs (US$3.84 billion). This is an increase of 4.5% versus 2014, when the company's sales were 3.64 billion Swiss Francs. Sales of Pharma&biotech saw an increase that was more than double the company's growth rate: sales were up 10.4% in 2015, from 1.45 billion Swiss Francs to 1.60 billion Swiss Francs.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Lonza Group AG
  Stock Performance Chart for Lonza Group AG
  Stock Data: Recent Stock Performance:
  Current Price (10/14/2016): 182.00
(Figures in Swiss Francs)
1 Week -1.9%   13 Weeks 0.4%  
4 Weeks 8.4%   52 Weeks 32.2%  
Lonza Group AG Key Data:
  Ticker: LONN Country: Switzerland
  Exchanges: FRA GVA OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 3,803,000,000
(Year Ending Jan 2016).
Employees: 9,829
  Currency: Swiss Francs Market Cap: 9,515,439,570
  Fiscal Yr Ends: December Shares Outstanding: 52,282,635
  Share Type: Namenaktie Closely Held Shares:
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.